Navrhujeme alternativní způsob predikce vhodné velikosti hmoty levé komory (LK) u osob s normálním krevním tlakem (TK) a arteriální hypertenzí. V naší studii jsme hodnotili i případné souvislosti mezi novým ukazatelem nevhodné velikosti hmoty LK a vznikem infarktu myokardu (IM), cévních mozkových příhod (CMP) a perzistentní fi brilace síní (FS). Studie probíhala ve dvou fázích. V první bylo vyšetřeno 630 neléčených hypertoniků a 206 normotoniků měřením TK v ordinaci lékaře, echokardiografi cky, ambulantním monitorováním TK (AMTK) a neinvazivní analýzou centrální pulsové vlny (central pulse wave analysis, CPWA). Byla nalezena středně významná korelace (r = 0,58; p = 0,002) mezi indexem hmoty levé komory (left ventricular mass index, LVMI) na jedné straně a součinem systolického TK (STK) a end-diastolického rozměru (end-diastolic dimension, EDD) levé komory na straně druhé. Tato korelace byla podstatně těsnější než korelace LVMI s každým výše uvedeným prediktorem zvlášť, a navíc nebyla méně spolehlivá (inferiorní) než současná metoda výpočtu nevhodné LVM. Prokázali jsme, že navržený výpočet by bylo možno zpřesnit použitím AMTK nebo neinvazivní CPWA. Ve druhé fázi studie bylo 132 pacientů s esenciální hypertenzí opakovaně odesílaných do nemocnice rozděleno podle vhodnosti LVMI. U všech byly v průběhu pěti let zaznamenány příhody jako IM, CMP nebo perzistentní FS. Podle našich údajů byla nevhodná LVMI spojena s vyšším rizikem IM, zvláště u pacientů bez hypertrofi e LK.
Hemodynamic load is one of the main components, which determines the myocardial mass. An increase in blood pressure is a cause of myocardium overload in patients with arterial hypertension, that is why the interest to the relationship between blood pressure and myocardial mass is still unabated. Left ventricular mass is an important indicator of the severity of hypertensive heart disease. It refl ects the individual measure of cardiovascular risk. This fact is well-known and lies in the basis of some prognostic tools such as Framingham Score. But in some cases the usual cut-off levels of left ventricular hypertrophy do not refl ect the individual risk. It was shown that determination of inappropriateness of myocardial mass to the load had additional benefi ts concerning the risk stratifi cation in patients with arterial hypertension [1] .The most widespread algorithm for calculating of inappropriate left ventricular mass was proposed at the end of the 90s [2] . The idea that product of stroke volume and systolic blood pressure predicts left ventricular mass (LVM) is lying in its basis. Stroke volume could be calculated according to the data obtained using echocardiography, and systolic blood pressure -by offi ce BP measurement (OBP). This method of calculation of inappropriate LVM was used in some later researches [3, 4] . There were some attempts to adopt original equations for local population [5] and to improve it, for example, by using ambulatory BP monitoring (ABPM) [6] . Novel study shows the correlation of inappropriate LVM with enhanced accumulation of advanced glycation end products in skin [7] .
The aim of this study was to propose alternative method of LVM prediction in subjects with normal BP and arterial hypertension through exploration of LVM relationship with different methods of blood pressure measurement and echocardiography data. Another goal was to establish prognostic meaning of new indicator of LVM inappropriateness concerning such events as myocardial infarction, stroke and persistent atrial fi brillation.
Materials and methods
Design of the study was approved by local ethic committee. All participants signed the informed consent form. The study consisted of two stages.
On the fi rst stage untreated patients with arterial hypertension or persons without hypertension of both genders, aged 25 or more and those who signed informed consent form, took part in the study. The main goal of this stage was to determine the most applicable methods for inappropriate LVM calculation and compare them with the existing analogs. Exclusion criteria were as follows:
• • Hemodynamically signifi cant arrhythmias including persistent AF, atrioventricular or sinoatrial blocks of the II-III degree. • Unstable stenocardia at the day of involvement. The results of echocardiography and blood pressure measurement of consecutive subjects with and without hypertension were collected in the data bank. There were 630 hypertensive untreated patients and 206 persons with normal BP. BP was estimated using methods of OBP, ambulatory blood pressure monitoring (ABPM) and central pulse wave analysis (CPWA). OBP was measured with "Omron MX3" device. Systolic (SBP) and diastolic blood pressure (DBP) were calculated as a mean of 2 consequent readings obtained on the arm with the higher values.
Echocardiography was performed in all subjects. LVM was calculated by ASE method using 2-D guided M-mode. LVM was indexed to the body surface calculated by Du Bois formula: S (m 2 ) = W 0.425 × H 0.725 × 0.007184. Another parameter of LV model was relative wall thickening (RWT) calculated as ratio of sum of LV walls thickness to the end diastolic dimension (EDD).
CPWA was performed in 278 persons: 150 hypertensive and 128 normotensive subjects. ABPM was also carried out in most of them (150 hypertensive and 50 normotensive subjects). Echocardiography, OBP measurement and CPWA were executed at the same day and ABPM -in a day or maximum in 3 days after other procedures. 278 participants underwent applanation tonometry of the radial artery with "Sphygmocor XCEL" equipment (At-Cor Medical, Australia) for noninvasive CPWA. The pulse wave curve of the radial artery, obtained by Hi-Fi probe, was transformed into a central aortic pulse wave with the corresponding intra-aortic pressure values. Such parameters were used for the analysis:
CESBP -central end-systolic blood pressure CSBP -central systolic blood pressure CDBP -central diastolic blood pressure ABPM was performed in 200 subjects with ABPM 4-01 device ("Meditech", Hungary). We obtained values of mean systolic and diastolic pressures during 24 h, including mean values for SBP and DBP in active and passive periods. Night decrease of BP -diurnal index (DI) and percentage of exceeding BP measurements -hypertension load indexes (HI) during active and passive period of the day were also calculated for SBP and DBP.
On the second stage 132 consecutive patients with essential hypertension (EH) (treated and untreated), which were referred for ECG examination repeatedly within one year or more, were assessed for new cases of myocardial infarction (MI), stroke or persistent atrial fi brillation (AF). All other inclusion-exclusion criteria were similar to the fi rst stage of the study. The main task of this stage was to assess the association of LVM inappropriateness, calculated by original method, with such surrogate end-points as the risk of MI, stroke and persistent AF.
The median term of observation was 59.0 months (interquartile range 32.9-84.4 months). All patients were divided into group of patients with appropriate and inappropriate LVM index (LVMI) dependent on value of EDD × SBP/100.
Statistical methods
All obtained data were processed by statistical methods preformed in "Statistica 8.0" application. Data were checked for normality by Kolmogorov-Smirnov and Lilliefors tests. Linear regression model was used for normally distributed data. Multiple regression method was applied for the creation of prediction models. Mann-Whitney test was used for paired comparison. Frequency tables and 2 test were applied for calculation of CV events odds risk.
Results and discussion
The main features of hypertensive (EH) and normotensive (CG) groups are performed in Table 1 .
We studied pair correlations of LVMI and its possible predictors among anthropometric data and some other parameters. These results are refl ected in Table 2 .
We noted signifi cant correlations of LVMI with age, SBP, DBP and EDD. As for EDD the result is predictable, because LVMI depends on EDD. But the fact that the strength and signifi cance of correlation of EDD and SBP product with LVMI occurred more pronounced than each of them alone was rather unexpected. Fig. 1 demonstrates the relationship between actual values of LVMI and parameter of EDD × SBP/100. This correlation had a high confi dential level as for the entire model (p < 0.001), for the regression coeffi cient and intercept (p < 0.001 for both).
We hypothesized that the actual LVMI value could be inappropriate to the certain BP level if it exceeded 95% confi dential interval (95% CI) of EDD × SBP/100. After calculations of 95% CI, values of EDD × SBP/100 exceeded more than 41% were determined as cut-off values for inappropriate left ventricular hypertrophy. We found that in persons with normal BP and hypertension the correlation coeffi cients of actual LVMI and EDD × SBP/100 were similar: in the control group it was 0.59 and in EH group -0.57 (p < 0.001 for both). According to that fact we have made an assumption that EDD × SBP/100 value could be applied as a universal indicator (for normo-and hypertensive subjects of any gender) of inappropriate left ventricular mass. The model for calculation of cut-off value for LVMI was (1), where LVMI -left ventricular mass index (g/m 2 ), EDDend diastolic dimension (mm), SBP -offi ce systolic blood pressure (mm Hg) Also we believed that if predicted values obtained by proposed model had correlation coeffi cient with LVMI similar to the values obtained by MAVI method, proposed model could have a similar prognostic signifi cance. Calculations of inappropriate LVM based on MAVI equation were the following:
(2) where LVM -predicted left ventricular mass, SW -stroke work, calculated as and "gender" is equal to 1 for males and 2 for females.
After calculations we determined that predicted values in persons with hypertension correlated with actual LVM similar to the values obtained by original method (r = 0.59; p < 0.001 and r = 0.57; p < 0.001, respectively). It was found that there was a strong pair correlation (r = 0.79; p < 0.001) between predicted values obtained by both methods.
We tried to improve our model by using of ABPM and CPWA parameters. Some weak, but signifi cant correlations of ABPM parameters with LVMI, were found ( Table  2 ). SBP daily , DId were the most signifi cant predictors. It was revealed that the correlation of LVMI with product of SBP daily , DId and EDD (r = 0.64; p < 0.001) was more pronounced than with product of EDD and SBP (r = 0.56; p = 0.01). Moreover, it was noted that R 2 for the model using ABPM parameters rose from 0.31 to 0.41.
(3) where LVMI -left ventricular mass index (g/m 2 ), EDD -end diastolic dimension (mm), SBP daily -daily systolic blood pressure (mm Hg)
The next step was to shift from OBP to CPWA values in equation for inappropriate LVMI calculation. CSBP had the most signifi cant correlation with LVMI, that is why our attention was focused mainly on this parameter. Use of CSBP values instead of SBP in Eq. (1) improved the power of model from 0.56 to 0.74 (p < 0.001 for both).
On the next stage we studied the role of inappropriate LVMI in patients using retrospective analysis of medical history. There were 132 hypertensive patients divided in 2 groups: with appropriate (51 persons) and inappropriate LVMI (81 persons). The majority of anthropometric data in both groups were similar, excluding SBP and DBP (Table 3).
All main classes of antihypertensive drugs and their combinations were used for patients' treatment: ACE inhibitors, AT 1 receptors antagonists, diuretics, calcium antagonists and beta-blockers. There were 34 naive patients and 98 on treatment regimen.
We provided the semi-quantitative scale for the assessment of AHT effectiveness: 0 -Ineffective AHT: patient noticed no BP decrease by home self-assessment. OBP was over target goal. 1 -Moderate effectiveness of AHT: decrease in BP self-assessment within 15%. OBP was over target goal. 2 -Effective AHT: self-assessment and OBP data was below target goal. 56 patients were referred to ineffective AHT, including 34 without any treatment and 22 with non-effective AHT; 56 -to the group with moderate effect of AHT and 20 -to the group with enough effect of treatment. The analysis of AHT showed similar average estimate of AHT effectiveness in both groups (with appropriate and inappropriate LVMI): 0.72 and 0.85, respectively (p > 0.05 based on Mann-Whitney U test). Thus, both groups were very similar not only by their clinical characteristics, but also by the results of AHT. So, it allowed us to calculate odds ratio of cardiovascular events in patients with inappropriate LVMI (Table 4) .
Inappropriate LVMI was associated with a 4.7 fold risk of MI, but was not associated with stroke or persistent AF. Moreover, inappropriate LVMI was revealed in 7 of 15 patients with new MI and no signs of LV hypertrophy assessed by routine method. Thus, we supposed the important prognostic meaning of LVMI inappropriateness for hypertensive patients without LV hypertrophy.
LVM estimation is one of the key points for patients' total risk assessment. It was shown that some additional benefi t could be observed using inappropriate LVM calculation instead of routine LVM measurement. In the MAVI study the level of fatal and non-fatal events in patients with inappropriate hypertrophy was signifi cantly higher than in those with appropriate or low myocardial mass. Also it was revealed that observed LVM/predicted LVM ratio, either in persons with or without hypertrophy, had additional predictive value [1] . We expected that as our method of inappropriate LVM assessment compared with MAVI method demonstrated similar correlation with observed LVM readings, it could have similar prognostic meaning. The infl uence of inappropriate LVMI on the incidence of secondary end-points during approximately 5 years proved this assumption. Signifi cant association of inappropriate LVMI with the incidence of MI, especially among patients with normal LVMI was shown. Easy way of appropriate LVMI cut-off calculation by the formula: EDD × SBP/100 + 41% make it useful in the routine practice. We also demonstrated that additional benefi t could be obtained by using ABPM data: SBP daily and DId. Another way to predict inappropriate LVMI was to change SBP by CSBP readings of CPWA. It gave some additional increase of predicting power compared with SBP.
Conclusion
Preliminary results showed that alternative method of appropriate left ventricular hypertrophy prediction could be at least as good as the widespread method. We also believe that ABPM and CPWA could improve statistical reliability of appropriate LVM prediction. In particular, CSBP instead of SBP showed better power of correlation and DId gave a better power and signifi cance of SBP × EDD product.
Limitations
The conclusions about predictive meaning of our method are based on correlation of well-known and proposed formulas and the results obtained in rather small prospective group with a few cardiovascular events. Another limitation is a secondary nature of end-points in our prospective study. Additional prospective studies using proposed formulas should be provided to prove the association of LVMI inappropriateness with primary end-points such as 
